Eric Christian Johannsen MD
Assistant Professor, Medicine, University of Wisconsin School of Medicine
Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-0946
Are you Dr. Johannsen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric Johannsen, MD is an infectious disease specialist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Massachusetts. He is an Assistant Professor at University of Wisconsin School of Medicine.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1998 - 2001
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995
Certifications & Licensure
WI State Medical License 2011 - 2025
MA State Medical License 2000 - 2013
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsEpstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms.Alejandro Casco, Makoto Ohashi, Eric Johannsen
Cell Reports. 2024-10-22 - Human CD4iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma.Dana C Baiu, Akshat Sharma, Jennifer L Schehr, Jayati Basu, Kelsey A Smith
Immunology. 2024-08-01 - 2 citationsLatent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.Jillian A Bristol, Scott E Nelson, Makoto Ohashi, Alejandro Casco, Mitchell Hayes
Plos Pathogens. 2024-04-01
Press Mentions
- Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene ProductJanuary 25th, 2021
Grant Support
- Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomasUNIVERSITY OF WISCONSIN-MADISON2022–2027
